Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (321-330 of 361) with videos related to

Pageof 37
Sort By:
Leukemia|December 14, 2018
CD34<sup>+</sup>CD38<sup>-</sup> leukemic stem cell frequency to predict outcome in acute myeloid leukemiaWendelien Zeijlemaker, Tim Grob, Rosa Meijer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDiana Averbuch, Julien De Greef, Amelie Duréault, et al.
Plos One|September 12, 2013
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Blood|May 10, 2024
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, et al.
Blood|January 5, 2017
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AMLBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
Research Square|December 16, 2024
Albumin orchestrates a natural host defense mechanism against mucormycosisAntonis Pikoulas, Ioannis Morianos, Vassilis Nidris Nidris, et al.
Intensive Care Medicine|June 23, 2021
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosisPaul E Verweij, Roger J M Brüggemann, Elie Azoulay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Bone Marrow Transplantation|February 11, 2023
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDSClaire Michel, Marie Robin, Stephane Morisset, et al.
American Journal of Hematology|May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Pageof 37

Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
Leukemia|December 14, 2018
CD34<sup>+</sup>CD38<sup>-</sup> leukemic stem cell frequency to predict outcome in acute myeloid leukemiaWendelien Zeijlemaker, Tim Grob, Rosa Meijer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDiana Averbuch, Julien De Greef, Amelie Duréault, et al.
Plos One|September 12, 2013
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Blood|May 10, 2024
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, et al.
Blood|January 5, 2017
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AMLBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
Research Square|December 16, 2024
Albumin orchestrates a natural host defense mechanism against mucormycosisAntonis Pikoulas, Ioannis Morianos, Vassilis Nidris Nidris, et al.
Intensive Care Medicine|June 23, 2021
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosisPaul E Verweij, Roger J M Brüggemann, Elie Azoulay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Bone Marrow Transplantation|February 11, 2023
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDSClaire Michel, Marie Robin, Stephane Morisset, et al.
American Journal of Hematology|May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Pageof 37